HLA B*44: protective effects in MS susceptibility and MRI outcome measures. by Chao, M, Lincoln, MR, Dyment, D, Ramagopalan, S, Ebers, G

Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. by Goedert, M, Fine, A, Dawbarn, D, Wilcock, G, Chao, M

Parental transmission of MS in a population-based Canadian cohort. by Herrera, B, Ramagopalan, S, Orton, S, Chao, M, Yee, I, Sadovnick, A, Ebers, G

Discussion by Chao, M, Sklar, P, Akil, H, Owen, M, Brandon, N, Flint, J

Parent-of-origin effects in MS: observations from avuncular pairs. by Herrera, B, Ramagopalan, S, Lincoln, MR, Orton, S, Chao, M, Sadovnick, A, Ebers, G

Discussion by Chao, M, Buonanno, A, Lu, B, Flint, J, Javitt, D, Talmage, D

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex by Chao, M, Ramagopalan, S, Herrera, B, Lincoln, M, Dyment, D, Sadovnick, A, Ebers, G

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. by Chao, M, Ramagopalan, S, Herrera, B, Lincoln, MR, Dyment, D, Sadovnick, A, Ebers, G

Fine Mapping of Epigenetic Modifications in Multiple Sclerosis Susceptibility by Chao, M, Lockstone, H, Ramagopalan, S, Herrera, B, Lincoln, MR, Sadovnick, A, Ebers, G

AML-399 A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment... by Vyas, P, Daver, N, Chao, M, Xing, G, Renard, C, Ramsingh, G, Sallman, D

A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acut... by Vyas, P, Daver, N, Chao, M, Xing, G, Renard, C, Ramsingh, G, Wei, AH, Sallman, DA

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. by Lincoln, MR, Ramagopalan, S, Chao, M, Herrera, B, Deluca, G, Orton, S, Dyment, D, Sadovnick, A, Ebers, G

Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis. by Chao, M, Herrera, B, Ramagopalan, S, Deluca, G, Handunetthi, L, Orton, S, Lincoln, MR, Sadovnick, A, Ebers, G

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. by Orton, S, Morris, A, Herrera, B, Ramagopalan, S, Lincoln, MR, Chao, M, Vieth, R, Sadovnick, A, Ebers, G

A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute mye... by Daver, N, Vyas, P, Chao, M, Xing, G, Renard, C, Ramsingh, G, Sallman, DA, Wei, AH

MHC transmission: insights into gender bias in MS susceptibility. by Chao, M, Ramagopalan, S, Herrera, B, Orton, S, Handunnetthi, L, Lincoln, MR, Dyment, D, Sadovnick, A, Ebers, G

Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. by Chao, M, Barnardo, M, Lui, G, Lincoln, MR, Ramagopalan, S, Herrera, B, Dyment, D, Sadovnick, A, Ebers, G

Epistasis among HLA-DRB1, HLA-DQA1 and HLA-DQB1 Loci Determines Multiple Sclerosis Susceptibility by Lincoln, MR, Ramagopalan, S, Chao, M, Herrera, B, DeLuca, G, Orton, S, Dyment, D, Sadovnick, A, Ebers, G

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. by Orton, S, Ramagopalan, S, Para, A, Lincoln, MR, Handunnetthi, L, Chao, M, Morahan, J, Morrison, K, Sadovnick, A, Ebers, G

Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium by Chao, M, Lui, G, Barnardo, M, Lincoln, MR, Ramago-Palan, S, Herrera, B, Dyment, D, Sadovnick, A, Ebers, G